eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

From FDA reports: drug interactions between Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride for a Female patient aged 32

This is a personalized study for a 32 year old female patient. The study is created by eHealthMe based on reports of 2 people who take the same drugs and have drug interactionsfrom FDA.

On Aug, 29, 2014: 2 people who reported to have interactions when taking Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride are studied

Trend of Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride's drug interactions, side effects, and effectiveness reports (2881610)

Information of the patient in this study:

Age: 32

Gender: female

Conditions: Epidural Anaesthesia, Spinal Anaesthesia, Blood Pressure Decreased

Drugs taking:
- Naropin: used for < 1 month
- Marcaine Hydrochloride Preservative Free: used for < 1 month
- Morphine Hydrochloride: used for < 1 month
- Morphine Hydrochloride: used for < 1 month
- Ephedrine Hydrochloride: used for < 1 month

Drug interactions have: Muscular Weakness, Sensory Disturbance

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 32 (±5):

InteractionNumber of reports
Muscular Weakness (muscle weakness)2 (100.00%)
Sensory Disturbance (sense disturbance)2 (100.00%)

Most common interactions experienced by females aged 32 (±5) in the use of Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride:

InteractionNumber of reports
Muscular Weakness (muscle weakness)2
Sensory Disturbance (sense disturbance)2
Blood Pressure Decreased (abnormally low blood pressure)2
Drug Exposure During Pregnancy2
Monoplegia (a paralysis of a single limb)2
Hypoaesthesia (reduced sense of touch or sensation)2

Most common interactions experienced by females aged 32 (±5) in long term use of Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Muscular Weakness (muscle weakness)2 (100.00%)
Sensory Disturbance (sense disturbance)2 (100.00%)

Most common interactions experienced by people in the use of Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride:

InteractionNumber of reports
Muscular Weakness (muscle weakness)2
Sensory Disturbance (sense disturbance)2
Blood Pressure Decreased (abnormally low blood pressure)2
Drug Exposure During Pregnancy2
Monoplegia (a paralysis of a single limb)2
Hypoaesthesia (reduced sense of touch or sensation)2

Most common interactions experienced by people in long term use of Naropin, Marcaine Hydrochloride Preservative Free, Morphine Hydrochloride, Ephedrine Hydrochloride:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

 

Recent mobile support groups

- Subclavian Artery Stenosis

- Cytomegalovirus Infection and Vertigo

- Flexeril for Fibromyalgia

- Lightheadedness and Emphysema

- Levothyroxine Sodium

 

Recent user comments

- "Since starting Latuda I have noticed a sharp increase ... " (16 minutes ago)

- "Been on protonix for 3 weeks when the pain, swelling, ... " (33 minutes ago)

- "Did not notice until started Finasteride, but might h ... " (3 hours ago)

 

Recent searches

- Implant Site Scar
- Pedunculate Oak
- Lymphoplasmacytoid Lymphoma Immunocytoma Stage Iv
- Subacute Combined Degeneration Of The Spinal Cord
- Vyvanse (shire Development) 70mg

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.